Astrazeneca

Actavis welcomes AZ in boosting its LAMA/LABA

Actavis welcomes AZ in boosting its LAMA/LABA

By Dan Stanton

Actavis says it is excited to partner with AstraZeneca over its long-acting muscarinic antagonist/beta-agonist (LAMA/LABA) fixed dose combination respiratory drug following the latter’s acquisition of Almirall.

Question? Sinequa will index data to answer AstraZeneca's queries. (Picture: Flickr/Roland O'Daniel)

AZ picks Sinequa to index millions of R&D docs

By Fiona BARRY

AstraZeneca has chosen big data and analytics services provider Sinequa, to index millions of R&D documents for use in a search platform providing “sub-second” answers to research questions.  

(Picture credit: flickr/Evinella)

Fifth major deal for Unilife injectables

By Fiona Barry

Injectable device manufacturer Unilife has announced a contract with a pharmaceutical multinational for the use of its Ocu-ject eye syringe, marking its fifth major contract in four months.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers